Transitioning to the novel risdiplam tablet formulation: Optimizing care and enhancing quality of life for adult patients with spinal muscular atrophy

Branka Pashaliska Cvetkov, Ivan Barbov, Dragana Cvetkovska Petrovska, Jasmina Korunoska

Open source

DOI
10.33320/maced.pharm.bull.2026.72.03.249
Published
10
Container
Makedonsko Farmacevtski Bilten
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.33320/maced.pharm.bull.2026.72.03.249,
  title = {Transitioning to the novel risdiplam tablet formulation: Optimizing care and enhancing quality of life for adult patients with spinal muscular atrophy},
  author = {Branka Pashaliska Cvetkov and Ivan Barbov and Dragana Cvetkovska Petrovska and Jasmina Korunoska},
  year = {2026},
  journal = {Makedonsko Farmacevtski Bilten},
  doi = {10.33320/maced.pharm.bull.2026.72.03.249},
  url = {https://doi.org/10.33320/maced.pharm.bull.2026.72.03.249}
}

RIS

TY  - JOUR
TI  - Transitioning to the novel risdiplam tablet formulation: Optimizing care and enhancing quality of life for adult patients with spinal muscular atrophy
AU  - Branka Pashaliska Cvetkov
AU  - Ivan Barbov
AU  - Dragana Cvetkovska Petrovska
AU  - Jasmina Korunoska
PY  - 2026
JO  - Makedonsko Farmacevtski Bilten
DO  - 10.33320/maced.pharm.bull.2026.72.03.249
UR  - https://doi.org/10.33320/maced.pharm.bull.2026.72.03.249
ER  - 

APA

Cvetkov, B. P., Barbov, I., Petrovska, D. C., & Korunoska, J. (2026). Transitioning to the novel risdiplam tablet formulation: Optimizing care and enhancing quality of life for adult patients with spinal muscular atrophy. Makedonsko Farmacevtski Bilten. https://doi.org/10.33320/maced.pharm.bull.2026.72.03.249

Source records